Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2009-9-4
pubmed:abstractText
It has been found that c-Myc protein plays a critical role in controlling self-renewal versus differentiation in hematopoietic stem cells. We report that c-Myc also controls the fate of megakaryocyte-erythrocyte progenitors through regulating the differentiation of erythroid and megakaryocytic progenitors. In addition to the significant reduction of granulocytes/macrophages and B and T lymphocytes because of the reduction of their corresponding progenitors, we found significantly increased numbers of megakaryocytic progenitors and mature megakaryocytes in bone marrow and spleens of c-Myc-knockout (c-Myc(-/-)) mice. Differentiation of erythrocytes was blocked at the erythroid progenitor stage. This increased megakaryocytopoiesis is a cell-intrinsic defect of c-Myc-mutant hematopoietic stem cells, as shown by transplantation studies. Furthermore, we found that c-Myc is required for polyploidy formation but not for cytoplasmic maturation of megakaryocytes. Megakaryocytes from c-Myc(-/-) mice are significantly smaller in size and lower in ploidy than those of control mice; however, because of the dramatic increase in megakaryocyte number, although fewer platelets are produced by each megakaryocyte, a greater than 3-fold increase in platelet number was consistently observed in c-Myc(-/-) mice. Thus, c-Myc(-/-) mice develop a syndrome of severe thrombocytosis-anemia-leukopenia because of significant increases in megakaryocytopoiesis and concomitant blockage of erythrocyte differentiation and reductions in myelolymphopoiesis.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1528-0020
pubmed:author
pubmed:issnType
Electronic
pubmed:day
3
pubmed:volume
114
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2097-106
pubmed:dateRevised
2010-9-6
pubmed:meshHeading
pubmed-meshheading:19372257-Anemia, pubmed-meshheading:19372257-Animals, pubmed-meshheading:19372257-B-Lymphocytes, pubmed-meshheading:19372257-Blood Platelets, pubmed-meshheading:19372257-Bone Marrow, pubmed-meshheading:19372257-Cell Differentiation, pubmed-meshheading:19372257-Cell Size, pubmed-meshheading:19372257-Erythrocytes, pubmed-meshheading:19372257-Erythroid Precursor Cells, pubmed-meshheading:19372257-Granulocytes, pubmed-meshheading:19372257-Leukopenia, pubmed-meshheading:19372257-Macrophages, pubmed-meshheading:19372257-Megakaryocyte Progenitor Cells, pubmed-meshheading:19372257-Megakaryocytes, pubmed-meshheading:19372257-Mice, pubmed-meshheading:19372257-Mice, Knockout, pubmed-meshheading:19372257-Ploidies, pubmed-meshheading:19372257-Proto-Oncogene Proteins c-myc, pubmed-meshheading:19372257-T-Lymphocytes, pubmed-meshheading:19372257-Thrombocytosis, pubmed-meshheading:19372257-Thrombopoiesis
pubmed:year
2009
pubmed:articleTitle
c-Myc-mediated control of cell fate in megakaryocyte-erythrocyte progenitors.
pubmed:affiliation
Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL 60153, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural